Tax-exempt hospitals participating in the 340B Drug Pricing Program provided nearly $100 billion in total community benefits in 2022. According to a September 2025 report from the American Hospital Association, 1,166 340B hospitals accounted for nearly $99.5 billion in total benefits — a $32 billion, or 47%, increase from 2019. Of that amount, about $46.4 billion went toward financial assistance, unreimbursed Medicaid costs and other means-tested government programs. Hospitals also reported more than $33.7 billion in other benefits such as health professions education, research and community group contributions.

Combined, financial assistance and other community benefits totaled $80.1 billion. Additional expenses included $370 million for community-building activities, a $17.5 billion Med

See Full Page